Dyne Therapeutics, Inc.DYN
Price (close)
$16.03
Market cap
$2.7B
P/E
—
Revenue (TTM)
—
Net income
-$519.4M
Dividend yield
—
1-year total return
27.4%
Net margin
—
Revenue growth
—
Debt / equity
0.28x
What Dyne Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$59.4M | -$149.3M | -$168.1M | -$235.9M | -$317.4M | -$446.2M |
| Free cash flow | -$47.7M | -$123.2M | -$156.7M | -$188.9M | -$294.7M | -$405.1M |
More on DYN.
- Dyne Therapeutics, Inc. summary
- Dyne Therapeutics, Inc. financial statements
- Dyne Therapeutics, Inc. key metrics
- Dyne Therapeutics, Inc. health scores and style box
- Dyne Therapeutics, Inc. earnings
- Dyne Therapeutics, Inc. dividends
- Dyne Therapeutics, Inc. valuation
- Dyne Therapeutics, Inc. ownership and insiders
- Dyne Therapeutics, Inc. peers
Figures from Dyne Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.